Author Page for G. Alexander

Economic Value of Treatment and Vaccine to Address the COVID-19 Pandemic: A U.S. Cost-Effectiveness and Budget Impact Analysis

Number of pages: 39 Posted: 01 Jun 2020

William V. Padula, William V. Padula, Shreena Malaviya, Natalie M. Reid, Jonothan Tierce and G. Alexander

University of Southern California - Schaeffer Center for Health Policy and EconomicsUniversity of Southern California - Department of Pharmaceutical & Health Economics, Monument Analytics, Monument Analytics, Monument Analytics and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Downloads 905 (39,904)

Citation 2

Abstract:

2.

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Downloads 39 (638,005)

Citation 2

2

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

NBER Working Paper No. w19948

Number of pages: 42 Posted: 03 Mar 2014 Last Revised: 02 Jan 2023

Robert Kaestner, Robert Kaestner, Cuiping Long and G. Alexander

University of ChicagoNational Bureau of Economic Research (NBER), University of Illinois at Chicago and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Downloads 38 (659,994)

Abstract:

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Journal of Risk and Insurance, Vol. 86, Issue 3, pp. 595-628, 2019

Number of pages: 34 Posted: 28 May 2020

Robert Kaestner, Robert Kaestner, Cuiping Schiman and G. Alexander

University of ChicagoNational Bureau of Economic Research (NBER), Pennsylvania State University Harrisburg and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Downloads 1 (1,003,029)

Citation 2

Abstract:

3.

COVID-19 Disease Severity Among People With HIV Infection or Solid Organ Transplant in the United States: A Nationally-Representative, Multicenter, Observational Cohort Study

Number of pages: 34 Posted: 28 Jul 2021

Jing Sun, Rena C. Patel, Qulu Zheng, Vithal Madhira, Amy L. Olex, Jessica Y. Islam, Evan French, Teresa Po-Yu Chiang, Hana Akselrod, Richard Moffitt, G. Alexander, Kathleen M. Andersen, Amanda J. Vinson, Todd T. Brown, Christopher G. Chute, Keith A. Crandall, Nora Franceschini, Roslyn B. Mannon, Gregory D. Kirk and National COVID Cohort Collaborative (N3C) Consortium

Johns Hopkins University - Department of Epidemiology, University of Washington - Department of Medicine, Johns Hopkins University - Department of Epidemiology, Palila Software, LLC, Virginia Commonwealth University (VCU) - School of Business, H. Lee Moffitt Cancer Center and Research Institute - Center for Immunization and Infection in Cancer, Virginia Commonwealth University (VCU) - School of Business, Johns Hopkins University, George Washington University - Division of Infectious Diseases, State University of New York (SUNY), Stony Brook, Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology, Johns Hopkins University - Department of Epidemiology, Dalhousie University - Department of Nephrology, Johns Hopkins University, School of Medicine, Division of Endocrinology, Diabetes, & Metabolism, Johns Hopkins University - School of Medicine, Milken Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of Nebraska Medical Center - Division of Nephrology, Johns Hopkins University - Department of Epidemiology and Independent

Downloads 37 (643,914)

Citation 1

Abstract:

4.

The Impact of Medicare Part D on Medicare-Medicaid Dual-Eligible Beneficiaries' Prescription Utilization and Expenditures

NBER Working Paper No. w14413

Number of pages: 29 Posted: 23 Oct 2008 Last Revised: 20 Nov 2022

Anirban Basu, Wesley Yin and G. Alexander

University of Chicago - Department of Medicine, University of Chicago - Harris School of Public Policy and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Downloads 33 (669,138)

Abstract:

5.

COVID-19 Unemployment and Access to Statin Medications in the United States

Johns Hopkins Carey Business School Research Paper No. 22-15

Number of pages: 31 Posted: 06 Aug 2022 Last Revised: 17 Oct 2022

Manuel Hermosilla, G. Alexander and Daniel Polsky

Johns Hopkins University - Carey Business School, Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology and Bloomberg School of Public Health, Department of Health Policy and Management, Johns Hopkins University

Downloads 27 (711,306)

Abstract:

6.

The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

Annual Review of Public Health, Vol. 36, pp. 559-574, 2015

Posted: 23 Mar 2015

Andrew Kolodny, David Courtwright, Catherine S. Hwang, Peter Kreiner, John L. Eadie, Thomas Clark and G. Alexander

Brandeis University - The Heller School for Social Policy and Management, University of North Florida, Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology, Brandeis University - The Heller School for Social Policy and Management, Brandeis University - The Heller School for Social Policy and Management, Brandeis University - The Heller School for Social Policy and Management and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Abstract:

7.

Rethinking Surrogate Decision-Making: Evidence from a Qualitative Study of Physicians

Journal of Clinical Ethics, Forthcoming

Posted: 13 Jan 2007 Last Revised: 20 Oct 2007

Alexia Torke, Mary Simmerling, Mark Siegler, Danit Kaya and G. Alexander

University of Chicago, Adler University, University of Chicago - Pritzker School of Medicine, University of Chicago and Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

G. Alexander

Johns Hopkins University - Department of Environmental Health Sciences and Epidemiology

Johns Hopkins University - Department of Medicine

Monument Analytics

7

1,041

2

3

Scholarly Papers (7)

Economic Value of Treatment and Vaccine to Address the COVID-19 Pandemic: A U.S. Cost-Effectiveness and Budget Impact Analysis

Abstract:

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Abstract:

Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D

Abstract:

COVID-19 Disease Severity Among People With HIV Infection or Solid Organ Transplant in the United States: A Nationally-Representative, Multicenter, Observational Cohort Study

Abstract:

The Impact of Medicare Part D on Medicare-Medicaid Dual-Eligible Beneficiaries' Prescription Utilization and Expenditures

Abstract:

COVID-19 Unemployment and Access to Statin Medications in the United States

Abstract:

The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

Abstract:

Rethinking Surrogate Decision-Making: Evidence from a Qualitative Study of Physicians

Abstract: